(Q71002250)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

The electrophysiological effects of intravenous labetalol in man (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

The electrophysiological effects of intravenous Labetalol in man (English)

1 reference

electrophysiological effect

27 April 2024

main subject

1 reference

A. Harley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7308279

27 April 2024

H. A. Coverdale

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7308279

27 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7308279

27 April 2024

publication date

1 January 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

15 October 2019

http://link.springer.com/content/pdf/10.1007/BF00618772.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00618772/fulltext.html

27 April 2024

1 reference

http://link.springer.com/content/pdf/10.1007/BF00618772

27 April 2024

1 reference

European Journal of Clinical Pharmacology

27 April 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

241-244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00618772

15 October 2019

exact match

0 references

cites work

Electrophysiological effects of acebutolol

1 reference

12 December 2020

A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug

1 reference

12 December 2020

The estimation of sinoatrial conduction time in rabbit heart by the constant atrial pacing technique

1 reference

12 December 2020

Pharmacological basis for antihypertensive effects of intravenous labetalol

1 reference

12 December 2020

The effects of propranolol on induction of A-V nodal reentrant paroxysmal tachycardia.

1 reference

12 December 2020

Electrophysiological properties of phentolamine in man

1 reference

12 December 2020

Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension

1 reference

12 December 2020

Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent

1 reference

12 December 2020

The Effects of Propranolol on Cardiac Conduction

1 reference

12 December 2020

Effect of phentolamine on atrioventricular conduction in man assessed by recording His bundle potential

1 reference

12 December 2020

A new method for measurement of sinoatrial conduction time

1 reference

12 December 2020

The electrophysiology of propranolol in man.

1 reference

12 December 2020

Some complementary data on AH 5158, an inhibitor of both alpha-and beta-adrenoceptors [proceedings]

1 reference

12 December 2020

Intravenous labetalol in hypertensive patients treated with beta-adrenoreceptor-blocking drugs

1 reference

12 December 2020

Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise

1 reference

12 December 2020

Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects

1 reference

12 December 2020

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

1 reference

12 December 2020

Labetalol infusion in acute myocardial infarction with systemic hypertension

1 reference

12 December 2020

Labetalol infusion in acute myocardial infarction with systemic hypertension

series ordinal

1

1 reference

Renal function, protein binding and pharmacological response to diazoxide

27 April 2024

series ordinal

4

1 reference

Clinical science and molecular medicine

27 April 2024

5

48

97

BNC Prichard

1975

1 reference

27 April 2024

Identifiers

DOI

10.1007/BF00618772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7308279%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference